Matches in Wikidata for { <http://www.wikidata.org/entity/Q91516350> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91516350 description "article scientifique publié en 2018" @default.
- Q91516350 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91516350 description "scientific article published on 24 August 2018" @default.
- Q91516350 description "wetenschappelijk artikel" @default.
- Q91516350 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91516350 name "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 name "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 type Item @default.
- Q91516350 label "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 label "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 prefLabel "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 prefLabel "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 P1433 Q91516350-973C1355-170D-4284-8A24-89C8810E69C1 @default.
- Q91516350 P1476 Q91516350-0178C664-2E72-4494-AF89-BDEBD765CBBB @default.
- Q91516350 P2093 Q91516350-2CCB5F92-39AC-4FFE-9780-E636A025F5EE @default.
- Q91516350 P2093 Q91516350-9926B095-B924-4FC8-96A0-DA9EA2CC448E @default.
- Q91516350 P304 Q91516350-2872A1CF-DEC9-48B1-A688-83EE0A2A9A40 @default.
- Q91516350 P31 Q91516350-604EBB12-CBDE-4751-9716-829FE44BA6AD @default.
- Q91516350 P356 Q91516350-3BC55736-E72D-4516-AE79-AFAB301AAB3F @default.
- Q91516350 P433 Q91516350-3AC27819-D22A-4809-8E20-1F4B1C408ADA @default.
- Q91516350 P478 Q91516350-58439BC0-E67E-416D-A78C-6C76646D7293 @default.
- Q91516350 P50 Q91516350-725FF0B8-DC9F-41FF-A842-936B3AF14D11 @default.
- Q91516350 P577 Q91516350-A73A9BC7-8C31-4FDD-82F8-B21880EEA644 @default.
- Q91516350 P698 Q91516350-E6345C67-303A-4D5A-A35D-3D94AA3FF1FE @default.
- Q91516350 P921 Q91516350-1D33F400-671E-42D0-B29B-C870F26239DF @default.
- Q91516350 P921 Q91516350-2AEA17F3-0923-4477-AF1A-D0B751D65B1C @default.
- Q91516350 P921 Q91516350-66BBFFCE-D7A8-47D6-A131-4F03FB0FAD66 @default.
- Q91516350 P356 J.CLCC.2018.08.003 @default.
- Q91516350 P698 30228027 @default.
- Q91516350 P1433 Q332277 @default.
- Q91516350 P1476 "Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States" @default.
- Q91516350 P2093 "Joel W Hay" @default.
- Q91516350 P2093 "Sang Kyu Cho" @default.
- Q91516350 P304 "e751-e761" @default.
- Q91516350 P31 Q13442814 @default.
- Q91516350 P356 "10.1016/J.CLCC.2018.08.003" @default.
- Q91516350 P433 "4" @default.
- Q91516350 P478 "17" @default.
- Q91516350 P50 Q91516346 @default.
- Q91516350 P577 "2018-08-24T00:00:00Z" @default.
- Q91516350 P698 "30228027" @default.
- Q91516350 P921 Q108566365 @default.
- Q91516350 P921 Q188874 @default.
- Q91516350 P921 Q25493920 @default.